136 related articles for article (PubMed ID: 6178590)
1. Role of pulmonary function tests in the prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratoma.
Lucraft HH; Wilkinson PM; Stretton TB; Read G
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):133-9. PubMed ID: 6178590
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.
Lauritsen J; Kier MG; Bandak M; Mortensen MS; Thomsen FB; Mortensen J; Daugaard G
J Clin Oncol; 2016 May; 34(13):1492-9. PubMed ID: 26903578
[TBL] [Abstract][Full Text] [Related]
3. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
Roncolato FT; Chatfield M; Houghton B; Toner G; Stockler M; Thomson D; Friedlander M; Gurney H; Rosenthal M; Grimison P;
Intern Med J; 2016 Aug; 46(8):893-8. PubMed ID: 27305276
[TBL] [Abstract][Full Text] [Related]
4. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
5. Role of carbon monoxide diffusing capacity in the early detection of major bleomycin-induced pulmonary toxicity.
Bell MR; Meredith DJ; Gill PG
Aust N Z J Med; 1985 Apr; 15(2):235-40. PubMed ID: 2411250
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme: an indicator of bleomycin-induced pulmonary toxicity in humans?
Sørensen PG; Rømer FK; Cortes D
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1405-8. PubMed ID: 6209143
[TBL] [Abstract][Full Text] [Related]
7. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
8. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of lung ventilation and carbon monoxide-diffusing capacity in patients with nonseminomatous testicular tumors treated with bleomycin.
Pagnoni A; Riboldi G; Valagussa P
Tumori; 1982 Feb; 68(1):85-9. PubMed ID: 6176056
[TBL] [Abstract][Full Text] [Related]
10. Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin.
Woods RL; Fox RM; Tattersall MH
Med J Aust; 1979 Dec; 2(12):630-2. PubMed ID: 94148
[TBL] [Abstract][Full Text] [Related]
11. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.
Einhorn LH; Donohue J
Ann Intern Med; 1977 Sep; 87(3):293-8. PubMed ID: 71004
[TBL] [Abstract][Full Text] [Related]
12. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
Kawai K; Hinotsu S; Tomobe M; Akaza H
Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
[TBL] [Abstract][Full Text] [Related]
13. Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Br J Cancer; 1995 Jan; 71(1):120-3. PubMed ID: 7529523
[TBL] [Abstract][Full Text] [Related]
14. The leakage of plasma albumin across small vessel walls during bleomycin treatment.
Sørensen PG; Groth S; Rossing N
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):29-32. PubMed ID: 6189719
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of metastatic testicular tumours.
Oliver RT; Rohatiner AA; Wrigley PF; Malpas JS
Br J Urol; 1980 Feb; 52(1):34-7. PubMed ID: 6159032
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
den Hollander MW; Westerink ND; Lubberts S; Bongaerts AH; Wolf RF; Altena R; Nuver J; Oosting SF; de Vries EG; Walenkamp AM; Meijer C; Gietema JA
Oncologist; 2016 Aug; 21(8):995-1001. PubMed ID: 27328932
[TBL] [Abstract][Full Text] [Related]
17. Impact of hemoglobin levels on hemoglobin-adjusted carbon monoxide diffusion capacity after chemotherapy for testicular cancer.
Nitta S; Kawai K; Nagumo Y; Ikeda A; Kandori S; Kojima T; Nishiyama H
Jpn J Clin Oncol; 2019 Dec; 49(12):1151-1156. PubMed ID: 31361805
[TBL] [Abstract][Full Text] [Related]
18. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
Krikorian JG; Daniels JR; Brown BW; Hu MS
Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
[TBL] [Abstract][Full Text] [Related]
19. A reduction in pulmonary capillary blood volume in patients with disseminated testicular carcinoma.
van Barneveld PW; Mulder NH; Sleijfer DT; van der Mark TW; Schraffordt Koops H; Sluiter HJ; Peset R
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):675-9. PubMed ID: 2410279
[TBL] [Abstract][Full Text] [Related]
20. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
